Saturday, March 1st, 2025

Resilient Growth and Upgraded Prospects: A Deep Dive into Hong Kong Exchanges and Clearing’s Q3 Performance

Date of Report: 24 October 2024
Broker Name: UOB Kay Hian


Company Overview

Hong Kong Exchanges and Clearing Limited (HKEx) owns and operates the stock exchange, futures exchange, and their related clearing houses in Hong Kong.

Stock Data

  • Share Price: HK$314.80
  • Target Price: HK$364.00
  • Upside: +15.6% (Previous Target Price: HK$355.00)
  • GICS Sector: Financials
  • Bloomberg Ticker: 388 HK
  • Shares Issued: 1,267.8 million
  • Market Cap: HK$399,115 million (US$51,366.8 million)
  • 3-Month Average Daily Turnover: US$438.1 million
  • 52-Week High/Low: HK$397.80 / HK$208.30

Price Performance

  • 1 Month: +30.3%
  • 3 Months: +36.0%
  • 6 Months: +45.8%
  • 1 Year: +14.2%
  • Year-to-Date: +21.6%

Major Shareholders

  • The Government of Hong Kong SAR: 5.8%

Key Financials (3Q24 Results)

  • Total Revenue: HK$5,372 million (-0.9% qoq, +5.7% yoy)
  • Core Revenue: HK$4,140 million (-1.8% qoq, +7.7% yoy)
  • Net Interest Income (NII) and Other Income: HK$1,232 million (+2.2% qoq, -0.6% yoy)
  • EBITDA: HK$3,926 million (-0.8% qoq, +5.9% yoy)
  • Net Profit: HK$3,145 million (-0.3% qoq, +6.5% yoy)
  • Earnings Per Share (EPS): HK$2.49 (-0.3% qoq, +6.5% yoy)
  • EBITDA Margin: 73.1% (+0.1 ppt yoy)
  • Net Profit Margin: 58.5% (+0.3 ppt yoy)

Performance Analysis

  • Earnings Growth: HKEX reported a 6.5% year-on-year earnings growth in Q3 2024, supported by a significant increase in average daily turnover (ADT) due to stimulus packages rolled out by China in late September.
  • Market Turnover: The ADT reached HK$118.8 billion, up 20.7% year-on-year, following a record-high ADT of HK$350.3 billion in the last five trading days of Q3 2024.
  • Revenue Growth: Revenue rose 5.7% year-on-year, driven by increased turnover and resilient NII, despite a slight miss in core revenue estimates.

Market Insights

  • Derivative and LME Performance: The average daily volume of derivative contracts surged 11% year-on-year to 1.48 million contracts in Q3 2024, while trading revenue from the London Metal Exchange (LME) jumped 31.7% year-on-year.
  • Cost Management: Operating expense growth, excluding depreciation and amortization, slowed to 4.7% year-on-year, contributing to an improved EBITDA margin.
  • IPO Activity: A notable increase in IPO funds raised to HK$42.2 billion in Q3 2024, with two significant IPOs expected to raise more than HK$10 billion.

Future Outlook

  • Earnings Revision: The broker raised the 2024 earnings forecasts by 2.8%, reflecting positive trends in headline ADT data and derivative assumptions.
  • Recommendation: Upgraded to BUY with a revised target price of HK$364.00, indicating a balanced risk-to-reward ratio after a recent correction in share price. The target price reflects a 34.3x 2024 forward PE ratio.

Conclusion

The report presents a positive outlook for Hong Kong Exchanges and Clearing, emphasizing its resilience and growth potential following recent market developments and robust performance metrics in Q3 2024.

Wilmar International: Expanding Stake in Adani Wilmar to 75% – Strategic Growth Move

Comprehensive Analysis of Wilmar International and Agribusiness Peers Comprehensive Analysis of Wilmar International and Agribusiness Peers Date: January 8, 2025 Broker: CGS International Wilmar International: A Strategic Move in Agribusiness Recommendation: Add Wilmar International...

Sunway REIT: Diverse Portfolio and Strong Growth Prospects Drive Investor Confidence

Date: October 2, 2024Broker: Maybank Investment Bank Berhad OverviewSunway REIT (SREIT MK) is one of Malaysia’s largest diversified REITs, with a portfolio spanning retail, office, hospitality, and industrial segments. Its assets are strategically located...

TOPVISION IPO: Eyeing Malaysia’s Thriving Healthcare Market with Strategic Growth Plans

TOPVISION IPO TOPVISION provides medical eye care services through 11 ambulatory care centers (ACCs) across Peninsular Malaysia, with plans to establish additional centers in Selangor, Terengganu, and Sabah. The Malaysian medical eye care industry...